Cargando…
Increasing Bioavailability of Trans-Ferulic Acid by Encapsulation in Functionalized Mesoporous Silica
Two types of mesoporous materials, MCM-41 and MCM-48, were functionalized by the soft-template method using (3-aminopropyl)triethoxysilane (APTES) as a modifying agent. The obtained mesoporous silica materials were loaded with trans-ferulic acid (FA). In order to establish the morphology and structu...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968071/ https://www.ncbi.nlm.nih.gov/pubmed/36839982 http://dx.doi.org/10.3390/pharmaceutics15020660 |
_version_ | 1784897423353577472 |
---|---|
author | Petrișor, Gabriela Motelica, Ludmila Ficai, Denisa Ilie, Cornelia-Ioana Trușcǎ, Roxana Doina Surdu, Vasile-Adrian Oprea, Ovidiu-Cristian Mȋrț, Andreea-Luiza Vasilievici, Gabriel Semenescu, Augustin Ficai, Anton Dițu, Lia-Mara |
author_facet | Petrișor, Gabriela Motelica, Ludmila Ficai, Denisa Ilie, Cornelia-Ioana Trușcǎ, Roxana Doina Surdu, Vasile-Adrian Oprea, Ovidiu-Cristian Mȋrț, Andreea-Luiza Vasilievici, Gabriel Semenescu, Augustin Ficai, Anton Dițu, Lia-Mara |
author_sort | Petrișor, Gabriela |
collection | PubMed |
description | Two types of mesoporous materials, MCM-41 and MCM-48, were functionalized by the soft-template method using (3-aminopropyl)triethoxysilane (APTES) as a modifying agent. The obtained mesoporous silica materials were loaded with trans-ferulic acid (FA). In order to establish the morphology and structure of mesoporous materials, a series of specific techniques were used such as: X-ray Diffraction (XRD), Scanning Electron Microscopy (SEM), Brunauer-Emmet-Teller (BET), Fourier Transform Infrared Spectroscopy (FTIR) and thermogravimetric analysis (TGA). We monitored the in vitro release of the loaded FA at two different pH values, by using simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). Additionally, Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853 and Candida albicans ATCC 10231 were used to evaluate the antimicrobial activity of FA loaded mesoporous silica materials. In conclusion such functionalized mesoporous materials can be employed as controlled release systems for polyphenols extracted from natural sources. |
format | Online Article Text |
id | pubmed-9968071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99680712023-02-27 Increasing Bioavailability of Trans-Ferulic Acid by Encapsulation in Functionalized Mesoporous Silica Petrișor, Gabriela Motelica, Ludmila Ficai, Denisa Ilie, Cornelia-Ioana Trușcǎ, Roxana Doina Surdu, Vasile-Adrian Oprea, Ovidiu-Cristian Mȋrț, Andreea-Luiza Vasilievici, Gabriel Semenescu, Augustin Ficai, Anton Dițu, Lia-Mara Pharmaceutics Article Two types of mesoporous materials, MCM-41 and MCM-48, were functionalized by the soft-template method using (3-aminopropyl)triethoxysilane (APTES) as a modifying agent. The obtained mesoporous silica materials were loaded with trans-ferulic acid (FA). In order to establish the morphology and structure of mesoporous materials, a series of specific techniques were used such as: X-ray Diffraction (XRD), Scanning Electron Microscopy (SEM), Brunauer-Emmet-Teller (BET), Fourier Transform Infrared Spectroscopy (FTIR) and thermogravimetric analysis (TGA). We monitored the in vitro release of the loaded FA at two different pH values, by using simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). Additionally, Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853 and Candida albicans ATCC 10231 were used to evaluate the antimicrobial activity of FA loaded mesoporous silica materials. In conclusion such functionalized mesoporous materials can be employed as controlled release systems for polyphenols extracted from natural sources. MDPI 2023-02-16 /pmc/articles/PMC9968071/ /pubmed/36839982 http://dx.doi.org/10.3390/pharmaceutics15020660 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Petrișor, Gabriela Motelica, Ludmila Ficai, Denisa Ilie, Cornelia-Ioana Trușcǎ, Roxana Doina Surdu, Vasile-Adrian Oprea, Ovidiu-Cristian Mȋrț, Andreea-Luiza Vasilievici, Gabriel Semenescu, Augustin Ficai, Anton Dițu, Lia-Mara Increasing Bioavailability of Trans-Ferulic Acid by Encapsulation in Functionalized Mesoporous Silica |
title | Increasing Bioavailability of Trans-Ferulic Acid by Encapsulation in Functionalized Mesoporous Silica |
title_full | Increasing Bioavailability of Trans-Ferulic Acid by Encapsulation in Functionalized Mesoporous Silica |
title_fullStr | Increasing Bioavailability of Trans-Ferulic Acid by Encapsulation in Functionalized Mesoporous Silica |
title_full_unstemmed | Increasing Bioavailability of Trans-Ferulic Acid by Encapsulation in Functionalized Mesoporous Silica |
title_short | Increasing Bioavailability of Trans-Ferulic Acid by Encapsulation in Functionalized Mesoporous Silica |
title_sort | increasing bioavailability of trans-ferulic acid by encapsulation in functionalized mesoporous silica |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968071/ https://www.ncbi.nlm.nih.gov/pubmed/36839982 http://dx.doi.org/10.3390/pharmaceutics15020660 |
work_keys_str_mv | AT petrisorgabriela increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica AT motelicaludmila increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica AT ficaidenisa increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica AT iliecorneliaioana increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica AT truscaroxanadoina increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica AT surduvasileadrian increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica AT opreaovidiucristian increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica AT mirtandreealuiza increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica AT vasilievicigabriel increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica AT semenescuaugustin increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica AT ficaianton increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica AT dituliamara increasingbioavailabilityoftransferulicacidbyencapsulationinfunctionalizedmesoporoussilica |